EPIVAX INC

Awards (most recent first)

• Validation and Improvement of ISPRI-HCP: An Innovative Platform for Immunogenicity Risk Assessment of Process-related Protein Impurities

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2023 · $299,917

  Aug 1, 2023 – Jul 31, 2024

  Solicitation PA21-259 (2021) · Topic NIAID

• GAA-ITEM: Personalizing the Prediction of Anti-therapeutic Antibody Response in Pompe Disease Patients

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $324,980

  May 9, 2018 – Apr 30, 2020

  Solicitation PA17-302 (2017) · Topic 999

• Novel Antigen-Specific Immunomodulatory Tregitope-based Therapy to Address Autoimmune Pathogenesis in Graves' Disease

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $316,862

  Sep 1, 2017 – Aug 31, 2019

  Solicitation PA16-302 (2016) · Topic 200

• Development of a Non adjuvanted VLP Vaccine against Stealth H N Influenza

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $590,546

  Jul 1, 2016 – Jun 30, 2019

  Solicitation PA14-071 (2014) · Topic NIAID

• Inducing Tolerance to Enzyme Replacement Therapy for Pompe Disease

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $600,000

  Solicitation PA10-123 (2012) · Topic NIAID · Research partner: Stub

• Combined Factor VIII Replacement and Tolerance Therapy for Hemophilia A

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $757,712

  Solicitation PA11-096 (2012) · Topic NHLBI · Research partner: Stub

• EpiVax Phase II SBIR: Preclinical studies of Tregitope Delivery and Mechanism of

  SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2012 · $1,474,236

  Solicitation PA11-096 (2012) · Topic NIDDK · Research partner: Stub

• T1D Tolerance Induction with Natural Treg Epitopes

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2008 · $599,999

  Solicitation PHS2007-2 (2008)

• Optimization of a Multivalent Tuberculosis Vaccine

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $299,908

  Solicitation year 2007

• Epitope-driven deimmunization of Factor VIII

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $263,867

  Solicitation year 2007

• Novel Smallpox Vaccine Derived from VV/VAR Immunome

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2005 · $1,027,410

  Solicitation PHS2005-2 (2005)

• A Genome-Derived, Epitope-Driven H. Pylori Vaccine

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2005 · $609,910

  Solicitation PHS2005-2 (2005)

• A GENOME-DERIVED, EPITOPE-DRIVEN TULAREMIA VACCINE

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2004 · $831,922

  Solicitation PHS2004-2 (2004)

• Diagnostic Reagents for Emerging Infectious Diseases

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2001 · $105,609

• Epitope driven HPV Vaccine Targeting Dentritic Cells

  SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2001 · $247,768

• EPITOPE-DRIVEN HIV VACCINE TARGETING DENDRITIC CELLS

  SBIR Phase I · Department of Health and Human Services · 1999 · $100,000